Insider Transactions in Q2 2022 at Aprea Therapeutics, Inc. (APRE)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2022
|
Eyal C. Attar SVP, Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,667
-36.34%
|
$0
$0.8 P/Share
|
|
Jun 03
2022
|
Gregory Alan Korbel SVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,390
-28.11%
|
$0
$0.8 P/Share
|
|
Jun 03
2022
|
Scott M Coiante SVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
35,284
-29.51%
|
$0
$0.8 P/Share
|
|
Jun 03
2022
|
Christian S Schade Director |
SELL
Payment of exercise price or tax liability
|
Direct |
65,770
-22.48%
|
$0
$0.8 P/Share
|
|
May 18
2022
|
Christian S Schade Director |
BUY
Open market or private purchase
|
Direct |
37,500
+11.36%
|
$0
$0.64 P/Share
|
|
May 18
2022
|
Bernd R. Seizinger Director |
BUY
Open market or private purchase
|
Direct |
50,000
+13.57%
|
$0
$0.71 P/Share
|